Published in Mol Cell Biol on March 01, 1994
mRNA stability in mammalian cells. Microbiol Rev (1995) 8.78
Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A (1995) 2.79
Identification and characterization of a sequence motif involved in nonsense-mediated mRNA decay. Mol Cell Biol (1995) 2.31
A novel phosphorylation-dependent RNase activity of GAP-SH3 binding protein: a potential link between signal transduction and RNA stability. Mol Cell Biol (1998) 2.21
RasGAP-associated endoribonuclease G3Bp: selective RNA degradation and phosphorylation-dependent localization. Mol Cell Biol (2001) 2.11
mRNA stabilization by poly(A) binding protein is independent of poly(A) and requires translation. Genes Dev (1998) 2.10
Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice. Mol Cell Biol (2004) 2.08
Erythroid cell-specific mRNA stability elements in the alpha 2-globin 3' nontranslated region. Mol Cell Biol (1995) 2.04
Erythroid cell-specific determinants of alpha-globin mRNA stability. Mol Cell Biol (1994) 1.96
The virion host shutoff protein of herpes simplex virus type 1: messenger ribonucleolytic activity in vitro. J Virol (1996) 1.95
Destabilization of interleukin-6 mRNA requires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1. Mol Cell Biol (2006) 1.77
Mechanisms of deadenylation-dependent decay. Wiley Interdiscip Rev RNA (2010) 1.69
Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant. Mol Cell Biol (2002) 1.43
Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol Biol Cell (1999) 1.42
mRNA instability elements in the human papillomavirus type 16 L2 coding region. J Virol (1998) 1.39
CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease. Nucleic Acids Res (2007) 1.29
The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing. Nucleic Acids Res (1996) 1.21
Identification of Apurinic/apyrimidinic endonuclease 1 (APE1) as the endoribonuclease that cleaves c-myc mRNA. Nucleic Acids Res (2009) 1.20
Identification of sequences in c-myc mRNA that regulate its steady-state levels. Mol Cell Biol (1996) 1.18
A human RNase E-like activity that cleaves RNA sequences involved in mRNA stability control. Proc Natl Acad Sci U S A (1995) 1.18
Regulatory role of the conserved stem-loop structure at the 5' end of collagen alpha1(I) mRNA. Mol Cell Biol (1999) 1.16
Iron regulatory elements (IREs): a family of mRNA non-coding sequences. Biochem J (1994) 1.15
Coding elements in exons 2 and 3 target c-myc mRNA downregulation during myogenic differentiation. Mol Cell Biol (1997) 1.04
Mechanisms of endonuclease-mediated mRNA decay. Wiley Interdiscip Rev RNA (2011) 1.03
Human La protein: a stabilizer of histone mRNA. Mol Cell Biol (1997) 1.00
Characterization of the cis-acting contributions to avian hepadnavirus RNA encapsidation. J Virol (2002) 0.98
Revisiting G3BP1 as a RasGAP binding protein: sensitization of tumor cells to chemotherapy by the RasGAP 317-326 sequence does not involve G3BP1. PLoS One (2011) 0.97
Chapter 3. Assays of adenylate uridylate-rich element-mediated mRNA decay in cells. Methods Enzymol (2008) 0.95
Coding region: the neglected post-transcriptional code. RNA Biol (2011) 0.95
Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex. Elife (2014) 0.93
Dcp2 decapping protein modulates mRNA stability of the critical interferon regulatory factor (IRF) IRF-7. Mol Cell Biol (2012) 0.91
A novel intron element operates posttranscriptionally To regulate human N-myc expression. Mol Cell Biol (1999) 0.88
Regulation of luteinizing hormone receptor mRNA expression by a specific RNA binding protein in the ovary. Mol Cell Endocrinol (2006) 0.87
A hyperactive transcriptional state marks genome reactivation at the mitosis-G1 transition. Genes Dev (2016) 0.86
Both coding exons of the c-myc gene contribute to its posttranscriptional regulation in the quiescent liver and regenerating liver and after protein synthesis inhibition. Mol Cell Biol (1995) 0.85
A single nucleotide change in the c-myc internal ribosome entry segment leads to enhanced binding of a group of protein factors. Nucleic Acids Res (1998) 0.83
Transdifferentiation of chicken embryonic cells into muscle cells by the 3' untranslated region of muscle tropomyosin. Proc Natl Acad Sci U S A (1995) 0.81
Exon 2-mediated c-myc mRNA decay in vivo is independent of its translation. Mol Cell Biol (1996) 0.80
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. Oncotarget (2015) 0.80
Identification of RNA instability elements in Borna disease virus. Virus Res (2009) 0.79
RNA-cleaving properties of human apurinic/apyrimidinic endonuclease 1 (APE1). Int J Biochem Mol Biol (2010) 0.78
Dynamic cohesin-mediated chromatin architecture controls epithelial-mesenchymal plasticity in cancer. EMBO Rep (2016) 0.75
The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects. Genes (Basel) (2017) 0.75
A human artificial chromosome recapitulates the metabolism of native telomeres in mammalian cells. PLoS One (2014) 0.75
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry (1977) 38.82
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (1984) 24.45
Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res (1985) 10.76
Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences. Cell (1985) 10.00
Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature (1985) 8.36
The nucleotide sequence of the human beta-globin gene. Cell (1980) 8.11
Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay. Genes Dev (1991) 7.51
The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev (1989) 7.03
The myc oncogene: its role in transformation and differentiation. Annu Rev Genet (1986) 5.40
A precursor of globin messenger RNA. J Mol Biol (1976) 5.34
Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res (1991) 4.60
A stem-loop in the 3' untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell (1988) 4.34
An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol Cell Biol (1991) 4.31
Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3' untranslated sequences. Mol Cell Biol (1987) 3.99
Poly(A) shortening and degradation of the 3' A+U-rich sequences of human c-myc mRNA in a cell-free system. Mol Cell Biol (1988) 3.96
New light on Myc and Myb. Part I. Myc. Genes Dev (1990) 3.57
The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev (1991) 3.33
Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant. Genes Dev (1992) 2.90
H4 histone messenger RNA decay in cell-free extracts initiates at or near the 3' terminus and proceeds 3' to 5'. J Mol Biol (1986) 2.63
Determinants that contribute to cytoplasmic stability of human c-fos and beta-globin mRNAs are located at several sites in each mRNA. Mol Cell Biol (1988) 2.46
U-rich sequence-binding proteins (URBPs) interacting with a 20-nucleotide U-rich sequence in the 3' untranslated region of c-fos mRNA may be involved in the first step of c-fos mRNA degradation. Mol Cell Biol (1992) 2.40
Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component. Mol Cell Biol (1989) 2.33
Poly(A) tail shortening is the translation-dependent step in c-myc mRNA degradation. Mol Cell Biol (1990) 2.06
c-myc RNA degradation in growing and differentiating cells: possible alternate pathways. Mol Cell Biol (1989) 1.67
Transfection of mouse erythroleukemia cells with myc sequences changes the rate of induced commitment to differentiate. Proc Natl Acad Sci U S A (1986) 1.63
A comparison of apparent mRNA half-life using kinetic labeling techniques vs decay following administration of transcriptional inhibitors. Anal Biochem (1991) 1.40
The destabilizing elements in the coding region of c-fos mRNA are recognized as RNA. Mol Cell Biol (1993) 1.34
Two cellular proteins bind specifically to a purine-rich sequence necessary for the destabilization function of a c-fos protein-coding region determinant of mRNA instability. Mol Cell Biol (1992) 1.27
Translation of c-myc mRNA is required for its post-transcriptional regulation during myogenesis. J Biol Chem (1990) 1.25
A 3' truncation of MYC caused by chromosomal translocation in a human T-cell leukemia increases mRNA stability. Oncogene (1990) 1.25
Enhancement of RNA polymerase II initiation complexes by a novel DNA control domain downstream from the cap site of the cytomegalovirus major immediate-early promoter. J Virol (1991) 1.20
Half-lives of beta and gamma globin messenger RNAs and of protein synthetic capacity in cultured human reticulocytes. Blood (1985) 1.15
Cleavage of nascent reovirus mRNA by localized activation of the 2'-5'-oligoadenylate-dependent endoribonuclease. J Virol (1984) 1.09
AUUUA motifs are dispensable for rapid degradation of the mouse c-myc RNA. Oncogene (1990) 1.07
Rapid c-myc mRNA degradation does not require (A + U)-rich sequences or complete translation of the mRNA. Nucleic Acids Res (1991) 1.06
Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease. Biochemistry (1987) 0.91
Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatic synthesis, properties, and biological activities of 2',5'-phosphorothioates from adenosine 5'-O-(2-thiotriphosphate) and adenosine 5'-O-(3-thiotriphosphate). Biochemistry (1987) 0.87
Phosphorothioate analogues of 2',5'-oligoadenylate. Activation of 2',5'-oligoadenylate-dependent endoribonuclease by 2',5'-phosphorothioate cores and 5'-monophosphates. Biochemistry (1987) 0.84
The myb and myc nuclear oncogenes as transcriptional activators. Curr Opin Cell Biol (1990) 0.81
Stochastic kinetic analysis of developmental pathway bifurcation in phage lambda-infected Escherichia coli cells. Genetics (1998) 12.21
In vitro synthesis of DNA complementary to purified rabbit globin mRNA (RNA-dependent DNA polymerase-reticulocyte-hemoglobin-density gradient centrifugation-oligo(dT) primer). Proc Natl Acad Sci U S A (1972) 7.89
Factors influencing infarct size following experimental coronary artery occlusions. Circulation (1971) 7.04
Fiber orientation in the canine left ventricle during diastole and systole. Circ Res (1969) 7.01
The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA (1997) 6.32
Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A (1991) 5.60
A precursor of globin messenger RNA. J Mol Biol (1976) 5.34
Phenological changes reflect climate change in Wisconsin. Proc Natl Acad Sci U S A (1999) 4.99
MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell (1997) 4.67
Globin messenger-RNA induction during erythroid differentiation of cultured leukemia cells. Proc Natl Acad Sci U S A (1972) 4.02
Poly(A) shortening and degradation of the 3' A+U-rich sequences of human c-myc mRNA in a cell-free system. Mol Cell Biol (1988) 3.96
Unstable beta-globin mRNA in mRNA-deficient beta o thalassemia. Cell (1981) 3.80
Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem (1998) 3.80
Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell (1999) 3.76
Separation of murine cellular and murine leukaemia virus DNA polymerases. Nat New Biol (1971) 3.71
The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol Cell Biol (1989) 3.69
Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis (1995) 3.66
Aortic stenosis. Circulation (1968) 3.49
Obliquity-paced Pliocene West Antarctic ice sheet oscillations. Nature (2009) 3.42
Cyclosporine-associated chronic nephropathy. N Engl J Med (1984) 3.39
Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation (1996) 3.34
Mean velocity of fiber shortening. A simplified measure of left ventricular myocardial contractility. Circulation (1971) 3.19
A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell (2001) 3.13
Long term acid suppressing treatment in general practice. BMJ (1994) 3.11
Selective suppression of the magnocellular visual pathway during saccadic eye movements. Nature (1994) 3.00
Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol (2004) 2.95
Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region stability determinant. Genes Dev (1992) 2.90
Poly(A), poly(A) binding protein and the regulation of mRNA stability. Trends Biochem Sci (1989) 2.78
A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A (2001) 2.77
Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci U S A (1998) 2.76
Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol (1982) 2.73
Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell (1999) 2.68
Immunological relationships of reverse transcriptases from ribonucleic acid tumor viruses. J Virol (1972) 2.65
H4 histone messenger RNA decay in cell-free extracts initiates at or near the 3' terminus and proceeds 3' to 5'. J Mol Biol (1986) 2.63
Regulation of mRNA turnover in eukaryotic cells. Crit Rev Eukaryot Gene Expr (1991) 2.62
Regional myocardial function during acute coronary artery occlusion and its modification by pharmacologic agents in the dog. Circ Res (1974) 2.57
A review and meta-analysis of the patient factors associated with psychiatric in-patient aggression. Acta Psychiatr Scand (2013) 2.48
A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nat Med (1998) 2.43
Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol (1988) 2.42
Estimation of VO2max from a one-mile track walk, gender, age, and body weight. Med Sci Sports Exerc (1987) 2.34
Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essential nucleic acid component. Mol Cell Biol (1989) 2.33
Skeletal repair by in situ formation of the mineral phase of bone. Science (1995) 2.33
Oxygen consumption of the heart. Newer concepts of its multifactoral determination. Am J Cardiol (1968) 2.29
Globin gene expression in cultured erythroleukemic cells. J Mol Biol (1974) 2.28
Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem (1995) 2.27
Precursors of alpha and beta globin messenger RNAs. J Mol Biol (1978) 2.26
Presentation with influenza-like illness in general practice: implications for use of neuraminidase inhibitors. Commun Dis Public Health (2000) 2.22
The precursor of mouse beta-globin messenger RNA contains two intervening RNA sequences. Cell (1978) 2.21
Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction (1996) 2.20
Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. Am J Cardiol (1972) 2.19
Tobacco use among middle and high school students--United States, 1999. MMWR Morb Mortal Wkly Rep (2000) 2.16
Assessment of cardiac contractility. The relation between the rate of pressure rise and ventricular pressure during isovolumic systole. Circulation (1971) 2.15
Velocity of contraction as a determinant of myocardial oxygen consumption. Am J Physiol (1965) 2.11
Mechanisms of calcium decay kinetics in hippocampal spines: role of spine calcium pumps and calcium diffusion through the spine neck in biochemical compartmentalization. J Neurosci (2000) 2.09
Can we talk? Inpatient discussions about advance directives in a community hospital. Attending physicians' attitudes, their inpatients' wishes, and reported experience. Arch Intern Med (1994) 2.09
Heroin-related deaths in New South Wales, Australia, 1992-1996. Drug Alcohol Depend (2000) 2.07
Histone mRNA degradation in vivo: the first detectable step occurs at or near the 3' terminus. Mol Cell Biol (1986) 2.07
Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci U S A (1996) 2.06
The VISA-A questionnaire: a valid and reliable index of the clinical severity of Achilles tendinopathy. Br J Sports Med (2001) 2.06
Discordance between cardiopulmonary physiology and physical therapy. Toward a rational basis for practice. Chest (1992) 2.06
Selective requirement of myosin light chain 2v in embryonic heart function. J Biol Chem (1998) 2.05
The mechanism of the intraventricular pressure gradient in idiopathic hypertrophic subaortic stenosis. Circulation (1966) 1.97
The virion host shutoff protein of herpes simplex virus type 1: messenger ribonucleolytic activity in vitro. J Virol (1996) 1.95
Chemical implementation of neural networks and Turing machines. Proc Natl Acad Sci U S A (1991) 1.90
Control of myocardial oxygen consumption: relative influence of contractile state and tension development. J Clin Invest (1968) 1.90
Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. J Clin Invest (1972) 1.86
Graduates of foreign medical schools: demographic and personal predictors of success on an OSCE-format internship programme entrance examination. Res Med Educ (1988) 1.86
Processing of the mouse beta-globin mRNA precursor: at least two cleavage-ligation reactions are necessary to excise the larger intervening sequence. Cell (1979) 1.84
Oscillations and control features in glycolysis: numerical analysis of a comprehensive model. Proc Natl Acad Sci U S A (1981) 1.84
Human beta-globin promoter and coding sequences transcribed by RNA polymerase III. Cell (1983) 1.84
The chlamydia screening studies: rationale and design. Sex Transm Infect (2004) 1.83
The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins. Nucleic Acids Res (1998) 1.82
Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure. J Clin Invest (1999) 1.82
Extraretinal control of saccadic suppression. J Neurosci (2000) 1.81
A comparison of globin genes in duck reticulocytes and liver cells. Biochem Biophys Res Commun (1972) 1.81
Geomapping of chlamydia and gonorrhoea in Birmingham. Sex Transm Infect (2000) 1.80
Oscillations and efficiency in glycolysis. Biophys Chem (1980) 1.79
Overdose among heroin users in Sydney, Australia: II. responses to overdose. Addiction (1996) 1.78
Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after the coronary occlusion. J Clin Invest (1972) 1.78
mRNA-deficient beta o-thalassemia results from a single nucleotide deletion. Nucleic Acids Res (1982) 1.78
Stress distribution in the canine left ventricle during diastole and systole. Biophys J (1970) 1.76
Purification and structural properties of the precursors of the globin messenger RNAs. J Mol Biol (1978) 1.75
Properties of the exonuclease activity that degrades H4 histone mRNA. J Biol Chem (1987) 1.74
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med (2006) 1.73
Chemical implementation of finite-state machines. Proc Natl Acad Sci U S A (1992) 1.72
Processing of human beta-globin mRNA precursor to mRNA is defective in three patients with beta+-thalassemia. Proc Natl Acad Sci U S A (1980) 1.72
ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol (1994) 1.66
An association between globin messenger RNA and 60S RNA derived from Friend leukemia virus. Proc Natl Acad Sci U S A (1974) 1.66
Effects of changing heart rate in man by electrical stimulation of the right atrium. studies at rest, during exercise, and with isoproterenol. Circulation (1965) 1.64
Contractile state of the left ventricle in man: instantaneous tension-velocity-length relations in patients with and without disease of the left ventricular myocardium. Circ Res (1968) 1.63
Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol (1996) 1.63
Separate visual representations for perception and action revealed by saccadic eye movements. Curr Biol (2001) 1.62
Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci U S A (1994) 1.59
Exploring the transcriptome of the malaria sporozoite stage. Proc Natl Acad Sci U S A (2001) 1.59
Potent inflammatory properties in human skin of interleukin-1 alpha-like material isolated from normal skin. J Invest Dermatol (1990) 1.59
Computational functions in biochemical reaction networks. Biophys J (1994) 1.58
Angiographic anatomy of the left ventricle and mitral valve in idiopathic hypertrophic subaortic stenosis. Circulation (1967) 1.58
Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. Oncogene (2007) 1.57
Mechanisms of contraction of the normal and failing heart. N Engl J Med (1967) 1.57
Atrial-like phenotype is associated with embryonic ventricular failure in retinoid X receptor alpha -/- mice. Proc Natl Acad Sci U S A (1995) 1.56